Bavarian Nordic shares rise 2% after board reaffirms takeover recommendation

Published 16/10/2025, 10:44
© Reuters

Investing.com -- Shares of Bavarian Nordic A/S rose 2% on Thursday following the biotechnology company’s board of directors reaffirming its recommendation that shareholders accept a voluntary takeover offer from Innosera ApS.

The board’s statement comes after an increase in the offer price and an extension of the offer period. 

The offer, made by Innosera, a company controlled by Nordic Capital Fund XI1 and funds managed and advised by Permira Beteiligungsberatung GmbH, seeks to acquire all issued and outstanding shares of Bavarian Nordic , excluding treasury shares.

Luc Debruyne, chair of the board, said the board continues to find the offer “fair and attractive,” citing the company’s fundamental value and share price levels prior to the public announcement of the takeover bid.

The board issued a supplementary statement following the publication of a second supplement to the offer document on October 15, confirming its unanimous decision to maintain the recommendation.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.